Theravance Biopharma TBPH
NASDAQ TBPH
$17.08 0.00 (-0.03%)
As of: Sep 4, 2026 · 3:16 PM EDT

Theravance Biopharma (TBPH) Change in Taxes (2014 - 2025)

Theravance Biopharma (TBPH) posted quarterly Change in Taxes of -$22.6 million for Q3 2025, down 605.75% quarter-over-quarter from $4.5 million in Q1 2018.

Analysis

Theravance Biopharma (TBPH) Change in Taxes (2014 - 2025) Analysis & Trends

Theravance Biopharma (TBPH) has reported Change in Taxes for 6 consecutive years, with -$22.6 million the latest figure, recorded in Q3 2025.

  • In Q3 2025, Change in Taxes changed N/A year-over-year to -$22.6 million; the TTM figure through Sep 2025 stood at -$21.1 million (changed N/A YoY), while the FY2017 annual figure was -$2.8 million, up 70.72% from the prior year.
  • Change in Taxes slipped to -$22.6 million in Q3 2025 per TBPH's latest filing, from $4.5 million in the prior quarter.
  • Across five years, Change in Taxes topped out at -$22.6 million in Q3 2025 and bottomed at -$22.6 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Taxes (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn -
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn -
5 Revolution Medicines 43.98 Bn 43.98 Bn - -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn -
8 Royalty Pharma 28.42 Bn 27.58 Bn - -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn -
10 Theravance Biopharma 882.21 Mn 494.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -22.62 Mn
Mar 31, 2018 4.47 Mn
Sep 30, 2017 -3.00 Mn
Jun 30, 2017 212,000.00
Dec 31, 2016 74,000.00
Sep 30, 2016 18,000.00
Jun 30, 2016 2.91 Mn
Mar 31, 2016 -12.52 Mn
Dec 31, 2015 9.65 Mn
Sep 30, 2015 94,000.00
Jun 30, 2015 3.01 Mn
Mar 31, 2015 10,000.00
Dec 31, 2014 -5.88 Mn